Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 12
1999 1
2000 1
2001 1
2002 1
2003 1
2005 2
2006 1
2012 3
2013 7
2014 2
2015 3
2016 1
2017 4
2018 4
2019 4
2020 5
2021 4
2022 8
2023 11
2024 44
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34324285

101 results

Results by year

Filters applied: . Clear all
Page 1
Rimegepant.
[No authors listed] [No authors listed] 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34324285 Free Books & Documents. Review.
Ubrogepant.
[No authors listed] [No authors listed] 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34324284 Free Books & Documents. Review.
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study).
Iannone LF, Vaghi G, Sebastianelli G, Casillo F, Russo A, Silvestro M, Pistoia F, Volta GD, Cortinovis M, Chiarugi A, Montisano DA, Prudenzano MP, Cevoli S, Mampreso E, Avino G, Romozzi M, Valente M, Fasano C, Battistini S, Granato A, Piella EM, Rainero I, Ornello R, De Icco R; Italian Headache Registry (RICe) Study Group. Iannone LF, et al. J Headache Pain. 2025 Jan 6;26(1):4. doi: 10.1186/s10194-024-01935-8. J Headache Pain. 2025. PMID: 39762740 Free PMC article.
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.
Yu S, Guo A, Wang Z, Liu J, Tan G, Yang Q, Zhang M, Yibulaiyin H, Chen H, Zhang Y, Croop R, Sun Y, Liu Y, Zhao Q, Lu Z. Yu S, et al. J Headache Pain. 2024 Apr 16;25(1):57. doi: 10.1186/s10194-024-01731-4. J Headache Pain. 2024. PMID: 38627638 Free PMC article. Clinical Trial.
Psychological therapies for the prevention of migraine in adults.
Sharpe L, Dudeney J, Williams ACC, Nicholas M, McPhee I, Baillie A, Welgampola M, McGuire B. Sharpe L, et al. Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD012295. doi: 10.1002/14651858.CD012295.pub2. Cochrane Database Syst Rev. 2019. PMID: 31264211 Free PMC article.
101 results